MDT - Medtronic beats top-line and bottom-line estimates; raises FY24 outlook
2024-02-20 06:47:47 ET
More on Medtronic
- Medtronic Is A Healthy Portfolio Boost
- Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
- Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative
- Medtronic Q3 in focus amid MedTech’s post-COVID gains
- Anti-obesity meds can expand the market for weight loss surgery: Bernstein